Examination of Lesions in the Urinary Bladder and Kidney of Dogs Induced by Nefiracetam, a New Nootropic Agent

Toxicologic Pathology

Volumn 24, Issue 5, 1996, Pages 549-557

  Kashida, Yoko ^a   Yoshida, Mitsuyosi ^a   Ish, Yoshikazu ^a   Nomura, Mamoru ^a   Kato, Michiyuki ^a  

^a DAIICHI SANKYO CO   (Japan)

Author keywords

collecting duct epithelium; hemorrhagic cystitis; papillary epithelium; Renal papillary necrosis

Indexed keywords

COLLAGEN; NEFIRACETAM; NOOTROPIC AGENT;

ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; DOG; EPITHELIUM CELL; FEMALE; HEMATURIA; HEMORRHAGIC CYSTITIS; HYPERPLASIA; KIDNEY PAPILLA NECROSIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; OSMOTIC PRESSURE; PRIORITY JOURNAL; URINALYSIS; URINE VOLUME;

ANIMALS; BLOOD CHEMICAL ANALYSIS; DOGS; FEMALE; HEMATURIA; KIDNEY; KIDNEY MEDULLA; MALE; NOOTROPIC AGENTS; PYRROLIDINONES; URINARY BLADDER; URINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029903645     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339602400503     Document Type: Article

References (34)

1. Brock N., Pohl J., and Stekar J. (1981). Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention-I. Experimental studies on the urotoxicity of alkylating compounds. Eur. J. Cancer 17: 595-607.
2. Burrell JH, Yong JLC, and MacDonald GJ (1991). Irreversible damage to the medullary interstitium in experimental analgesic nephropathy in F344 rats. J. Pathol. 164: 329-338.
3. Burry A. (1978). Pathology of analgesic nephropathy: Australian experience. Kidney Int. 13: 34-40.
4. Carmichael J. and Shankel SW (1985). Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am. J. Med. 78: 992-1000.
5. Durand-Cavagna G., Owen RA, Gordon LR, Peter CP, and Boussiquet-Leroux C. (1992). Urothelial hyperplasia induced by carbonic anhydrase inhibitors (CAIs) in animals and its relationship to urinary Na and p H. Fundam. Appl. Toxicol. 18: 137-143.
6. Elliott GA (1986). Papillary necrosis, rat. In: Urinary System, TC Jones, U Mohr, and RD Hunt (eds). Springer-Verlag, Berlin, Heidelberg, pp. 184–189.
7. Ellis BG, Price RG, and Topham JC (1973). The effect of papillary damage by ethyleneimine on kidney function and some urinary enzymes in the dog. Chem. Biol. Interact. 7: 131-142.
8. Fraiser L. and Kehrer JP (1992). Murine strain differences in metabolism and bladder toxicity of cyclophosphamide. Toxicology 75: 257-272.
9. Gregg NJ, Courtauld EA, and Bach PH (1990). Enzyme histochemical changes in an acutely induced renal papillary necrosis. Toxicol. Pathol. 18: 39-46.
10. Gregg NJ, Courtauld EA, and Bach PH (1990). High resolution light microscopic morphological and microvascular changes in an acutely induced renal papillary necrosis. Toxicol. Pathol. 18: 47-55.
11. Hill GS, Wyllie RG, Miller M., and Heptinstall RH (1972). Experimental papillary necrosis of the kidney. II. Electron microscopic and histochemical studies. Am. J. Pathol. 68: 213-234.
12. Hooks WN, Burford P., Begg S., Gopinath C., Inage F., Kato M., and Takayama S. (1994). Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs. Arzneim.-Forsch./Drug Res. 44: 228-238.
13. Hooks WN, Colman KA, Gopinath C., Inage F., Kato M., and Takayama S. (1994). Fifty-two-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats. Arzneim.-Forsch./Drug Res. 44: 220-228.
14. Jindo T., Shimizu Y., Kato M., and Takayama S. (1994). Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in rats. Arzneim.-Forsch./Drug Res. 44: 214-216.
15. Kajimura T., Satoh H., Rajasekaran D., Spicer EJF, Nakashima N., and Takayama S. (1994). Oncogenicity studies of the cognition-enhancing agent nefiracetam in mice and rats. Arzneim.-Forsch./Drug Res. 44: 254-259.
16. Koss LG and Lavin P. (1970). Effects of a single dose of cyclophosphamide on various organs in the rat. II. Response of urinary bladder epithelium according to strain and sex. J. Natl. Cancer. Inst. 44: 1195-1200.
17. Lenz SD and Carlton WW (1990). Diphenylamine-induced renal papillary necrosis and necrosis of the pars recta in laboratory rodents. Vet. Pathol. 27: 171-178.
18. Macallum GE and Albassam MA (1994). Renal toxicity of nondopaminergic antipsychotic agent, trimethyl imidazopyrazolopyrimidine, in rats. Toxicol. Pathol. 22: 39-47.
19. Molland EA (1978). Experimantal renal papillary necrosis. Kidney Int. 13: 5-14.
20. Molon-Noblot S., Boussiquet-Leroux C., Owen RA, Irisarri E., Durand-Cavagna G., Peter CP, and Duprat P. (1992). Rat urinary bladder hyperplasia induced by oral administration of carbonic anhydrase inhibitors. Toxicol. Pathol. 20: 93-102.
21. Muirhead EE, Vanatta J., and Grollman A. (1950). Papillary necrosis of the kidney. A clinical and experimental correlation. J. Am. Med. Assoc. 142: 627-631.
22. Murasaki M., Inami M., Ishigooka J., Wakatabe H., Utsumi M., Matsumoto T., Fukuyama Y., Miura S., Tachizawa H., Sudo K., and Fujimaki Y. (1994). Phase I study on DM-9384 (nefiracetam). Jpn. Pharmacol. Ther. 22: 3539-3587.
23. Murray G., Wyllie RG, Hill GS, Ramsden PW, and Heptinstall RH (1972). Experimental papillary necrosis of the kidney. I. Morphologic and functional data. Am. J. Pathol. 67: 285-302.
24. Murray MD and Craig Brater D. (1993). Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annu. Rev. Pharmacol. Toxicol. 32: 435-465.
25. Okamura T., Garland EM, Taylor RJ, Johansson SL, and Cohen SM (1992). The effect of cyclophosphamide administration on the kidney of the rat. Toxicol. Lett. 63: 261-276.
26. Otomo E., Kogure K., Hirai S., Goto F., Hasegawa K., Tazaki Y., Ito E., Nishimura T., Fujishima M., Inanaga K., and Ogawa N. (1994). Clinical evaluation of DM-9384 in the treatment of cerebrovascular disorders: early Phase II study. Jpn. Pharmacol. Ther. 22: 3589-3624.
27. Owen RA, Durand-Cavagna G., Molon-Noblot S., Boussiquet-Leroux C., Berry PH, Tonkonoh N., Peter CP, and Gordon LR (1993). Renal papillary cytopalasmic granularity and potassium depletion induced by carbonic anhydrase inhibitors in rats. Toxicol. Pathol. 21: 449-455.
28. Philips FS, Sternberg SS, Cronin AP, and Vidal PM (1961). Cyclophosphamide and urinary bladder toxicity. Cancer Res. 21: 1577-1589.
29. Pohl J., Stekar J., and Hilgard P. (1989). Chloroacetaldehyde and its contribution to urotoxicity during treatment with cyclophosphamide or ifosfamide. An experimental study/Short communication. Arzneim.-Forsch./Drug Res. 39: 704-705.
30. Powell CJ, Grasso P., Ioannides C., Wilson J., and Bridges JW (1991). Haloalkylamine-induced renal papillary necrosis: A histopathological study of structure-activity relationships. Int. J. Exp. Pathol. 72: 631-646.
31. Sudo K., Hashimoto K., Fujimaki Y., and Tachizawa H. (1994). Disposition and metabolism of nefiracetam, a new nootropic agent, in the rat, dog and monkey. Jpn. Pharmacol. Ther. 22: 3441-3452.
32. Sugawara T., Kato M., Suzuki N., Akahane K., and Takayama S. (1994). Thirteen-week oral toxicity study of the new cognition-enhancing agent nefiracetam in dogs. Arzneim. -Forsch./Drug Res. 44: 217-219.
33. Toto RD (1991). The role of prostaglandins in NSAID induced renal dysfunction. J. Rheumatol. 18: 22-25.
34. Wolf DC, Carlton WW, and Turek JJ (1992). Experimental renal papillary necrosis in the Mongolian gerbil (Meriones unguiculatus). Toxicol. Pathol. 20: 341-349.